Pacific Biosciences's total assets for Q3 2024 were $1.45B, a decrease of -3.94% from the previous quarter. DE:P09 total liabilities were $996.93M for the fiscal quarter, a -1.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.